Xenon Pharmaceuticals Overview
Xenon Pharmaceuticals Target Price
Analysts' 12-month price predictions for XENE.
Get informed when a big investor buys or sells
+ FollowShare Price
$53.46
Average Target Price
$81.75
52.9% upside
52.9% upside12 analysts in the last 4 months
High: $100 | Low: $60
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-10 | Wells FargoBenjamin Burnett | $69 | 29.1% upside |  |
| 2026-05-08 | NeedhamSerge Belanger | $78 | 45.9% upside | |
| 2026-03-10 | Deutsche Bank | $90 | 68.4% upside | |
| 2026-03-09 | RBC Capital | $80 | 49.6% upside | |
| 2026-03-09 | JefferiesAndrew Tsai | $100 | 87.1% upside | |
| 2026-03-09 | GuggenheimYatin Suneja | $90 | 68.4% upside | |
| 2026-03-09 | Morgan Stanley | $97 | 81.4% upside | |
| 2026-03-09 | Robert W. Baird | $97 | 81.4% upside | |
| 2026-03-09 | Stifel NicolausPaul Matteis | $89 | 66.5% upside | |
| 2026-03-09 | JefferiesAndrew Tsai | $65 | 21.6% upside | |
| 2026-02-23 | Wolfe Research | $60 | 12.2% upside | |
| 2026-02-10 | Stifel Nicolaus | $66 | 23.5% upside | |
| 2025-11-04 | RBC Capital | $58 | 8.5% upside | |
| 2025-11-04 | Cantor FitzgeraldJosh Schimmer | $55 | 2.9% upside | |
| 2025-11-04 | Wells FargoBenjamin Burnett | $44 |  17.7% downside | |
| 2025-02-28 | Wedbush | $42 | 21.4% downside | |
| 2024-10-10 | Raymond JamesDanielle Brill | $50 | 6.5% downside | |
| 2024-10-01 | H.C. WainwrightDouglas Tsao | $53 | 0.9% downside | |
| 2024-08-09 | WedbushLaura Chico | $49 | 8.3% downside | |
| 2024-06-18 | RBC CapitalBrian Abrahams | $55 | 2.9% upside | |
| 2022-12-14 | Goldman Sachs | $60 | 12.2% upside | |
| 2022-11-28 | Wells Fargo | $50 | 6.5% downside | |
| 2022-11-11 | Guggenheim | $49 | 8.3% downside | |
| 2022-10-18 | Raymond JamesDanielle Brill | $52 | 2.7% downside | |
| 2022-08-11 | Leerink Partners | $46 | 14% downside | |
| 2022-08-10 | RBC Capital | $46 | 14% downside | |
| 2022-06-27 | Wedbush | $41 | 23.3% downside | |
| 2022-05-11 | RBC Capital | $41 | 23.3% downside | |